Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(... Continued)<br />
Study or subgroup AL6 AS+AQ Risk Ratio Risk Ratio<br />
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI<br />
Dorsey 2006 UGA 3/103 9/111 0.36 [ 0.10, 1.29 ]<br />
Kobbe 2007 GHA 18/109 20/108 0.89 [ 0.50, 1.59 ]<br />
Subtotal (95% CI) 984 1212 1.01 [ 0.78, 1.31 ]<br />
Total events: 96 (AL6), 102 (AS+AQ)<br />
Heterogeneity: Chi 2 = 6.19, df = 7 (P = 0.52); I 2 =0.0%<br />
Test <strong>for</strong> overall effect: Z = 0.05 (P = 0.96)<br />
6 Total Failure Day 28 PCR adjusted (losses to follow up included as successes)<br />
Faye 2003 SEN 0/149 0/360 0.0 [ 0.0, 0.0 ]<br />
Guthmann 2004 AGO 0/65 0/69 0.0 [ 0.0, 0.0 ]<br />
Falade 2005 NGA 0/66 0/66 0.0 [ 0.0, 0.0 ]<br />
Bukirwa 2005 UGA 5/204 1/204 5.00 [ 0.59, 42.42 ]<br />
Owusu-Agyei 2006 GHA 21/177 10/178 2.11 [ 1.02, 4.35 ]<br />
Dorsey 2006 UGA 0/103 3/111 0.15 [ 0.01, 2.94 ]<br />
Adjei 2006 GHA 4/111 2/116 2.09 [ 0.39, 11.18 ]<br />
Kobbe 2007 GHA 12/109 8/108 1.49 [ 0.63, 3.49 ]<br />
Subtotal (95% CI) 984 1212 1.75 [ 1.08, 2.83 ]<br />
Total events: 42 (AL6), 24 (AS+AQ)<br />
Heterogeneity: Chi 2 = 3.98, df = 4 (P = 0.41); I 2 =0.0%<br />
Test <strong>for</strong> overall effect: Z = 2.28 (P = 0.023)<br />
0.001 0.01 0.1 1 10 100 1000<br />
Favours AL6 Favours AS+AQ<br />
Analysis 10.1. Comparison 10 Artemether-lumefantrine vs Artesunate plus sulfadoxine-pyrimethamine,<br />
Outcome 1 Total Failure (P. falciparum) Day 42 PCR unadjusted.<br />
Review: <strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria<br />
Comparison: 10 Artemether-lumefantrine vs Artesunate plus sulfadoxine-pyrimethamine<br />
Outcome: 1 Total Failure (P. falciparum) Day 42 PCR unadjusted<br />
Study or subgroup AL6 AS+SP Risk Ratio Weight Risk Ratio<br />
1 Oceania<br />
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI<br />
Karunajeewa 2007 PNG 40/109 41/108 100.0 % 0.97 [ 0.68, 1.36 ]<br />
0.01 0.1 1 10 100<br />
Favours AL6 Favours AS+SP<br />
<strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria (Review)<br />
Copyright © 2009 <strong>The</strong> <strong>Cochrane</strong> Collaboration. Published by John Wiley & Sons, Ltd.<br />
176